Pickering Marie-Eva, Perrot Serge, Christian Dualé, Morel Véronique, Macian Nicolas, Pereira Bruno
Rheumatology Department, CHU Gabriel Montpied, Clermont-Ferrand 63000, France.
Pain Center, Cochin Hospital, INSERM U987, Paris Cité University, Paris, France.
Pain Res Manag. 2024 Dec 26;2024:9766698. doi: 10.1155/prm/9766698. eCollection 2024.
The neuropathic characteristics of pain occurring after an osteoporosis (OP)-related fracture are often under-recognized. The aim of this pilot study is to identify, in patients suffering from pain localized on the site of a previous osteoporotic fracture, the presence of neuropathic characteristics, their medical management, and their impact on quality of life. This pilot cross-sectional study on consecutive patients in University Hospital, Rheumatology Department, Clermont-Ferrand, France, was approved by the Ethics Committee (IRB number 2023-CF34). Pain was evaluated with the Numeric Pain Rating Scale (NPRS), Neuropathic Component of Chronic pain (NCCP) was screened with the DN4 questionnaire, and sleep was assessed with the Pittsburg questionnaire. Depression, anxiety, quality of life, and concomitant treatment were also evaluated. Results were expressed using effect sizes (ESs) and 95% confidence intervals. Fifty new patients with a history of at least one fully documented fragility vertebral fracture (VF) or nonvertebral fracture (NVF) due to osteoporosis, in the last 2 years minus the previous 6 months, were included. Findings show that 21% patients with VF and 28% patients with NVF reported NCCP (DN ≥ 4). NCCP patients had more intense pain (NPRS = 5.1 ± 2.9 vs. 2.9 ± 2.7, ES = 0.82 [0.18; 1.44], =0.019) and impaired sleep compared to patients without NCCP (ES = 0.71 [0.08; 1.33], =0.043). A remarkable point was that patients had no specific oral or topical treatment for NCCP and were only taking on demand paracetamol and nonsteroidal anti-inflammatory drugs. Future research should focus on the neuropathic characteristics of pain patients with OP, in order to better manage OP-related pain.
骨质疏松症(OP)相关骨折后疼痛的神经病理性特征常常未得到充分认识。这项初步研究的目的是,在既往骨质疏松性骨折部位出现疼痛的患者中,确定神经病理性特征的存在情况、其药物治疗以及对生活质量的影响。这项针对法国克莱蒙费朗大学医院风湿病科连续患者的初步横断面研究,已获得伦理委员会批准(IRB编号2023-CF34)。使用数字疼痛评分量表(NPRS)评估疼痛,用DN4问卷筛查慢性疼痛的神经病理性成分(NCCP),并用匹兹堡问卷评估睡眠情况。还对抑郁、焦虑、生活质量和伴随治疗进行了评估。结果用效应量(ESs)和95%置信区间表示。纳入了50名新患者,这些患者在过去2年减去前6个月内,有至少一次因骨质疏松导致的完全记录在案的脆性椎体骨折(VF)或非椎体骨折(NVF)病史。研究结果显示,21%的VF患者和28%的NVF患者报告有NCCP(DN≥4)。与无NCCP的患者相比,NCCP患者疼痛更剧烈(NPRS=5.1±2.9对2.9±2.7,ES=0.82[0.18;1.44],P=0.019)且睡眠受损(ES=0.71[0.08;1.33],P=0.043)。一个值得注意的点是,患者没有针对NCCP的特定口服或局部治疗,仅按需服用对乙酰氨基酚和非甾体抗炎药。未来的研究应聚焦于OP疼痛患者的神经病理性特征,以便更好地管理与OP相关的疼痛。